Integrichain Blog

Blog

Hd Specialty Pharmacy Patient Status Data Quality
Government Pricing Joseph Heimbecker, III
August 26, 2025

Taming Launch Data Chaos: Why Your Bespoke CDW Can’t Keep Pace

2 Minute Read

The pharmaceutical landscape, particularly during launch, is drowning in data. Specialty Pharmacy (SP) and Specialty Distributor (SD) data streams are critical lifelines, offering insights into prescribing behavior, patient access,...

Finance Gtn Optimization

Government Pricing Clay Willis
July 17, 2025

340B: Are You Navigating and Staying Up to Date with the...

6 Minute Read

The 340B program stands out as one of the most dynamic and complex government programs. We will explore how and why we got here.

Evolving state price transparency laws

Market Access Blogs Lynetta Moore
July 7, 2025

State Price Transparency: How to Navigate Evolving Laws

4 Minute Read

At the recent Pricing and Contracting USA 2025 Conference, industry leaders came together to address the growing complexity and operational challenges of state price transparency compliance.

Market Strategy

Market Access Blogs Jordan Boruff Manli Gomari Michael Gorokhovsky
June 16, 2025

Unpacking Trump’s Drug Pricing Executive Order & the 2026 Part D...

8 Minute Read

This month, we offer commentary on two topics around Unpacking Part D Redesign in 2026 and Trump’s Drug Pricing Executive Order.

Net Revenue Pharma

Access Transformation Jen Sharpe Walt Worsham
June 3, 2025

Optimizing Pharma Net Revenue Under New Market Dynamics

4 Minute Read

This year's Asembia conference was highly impactful, offering deep insights into pharmaceutical manufacturers' top challenges and future commercial data needs, particularly highlighting the growing demand for real-time, integrated data...

pharmaceutical commercial data discussed at asembia conference 2025

Access Transformation Lauren Labik
May 30, 2025

Bringing Clarity to the Complexities of Pharma Commercial Data at Asembia...

4 Minute Read

This year's Asembia conference was highly impactful, offering deep insights into pharmaceutical manufacturers' top challenges and future commercial data needs, particularly highlighting the growing demand for real-time, integrated data...

Most Favored Nation Drug Pricing 2025 update

Market Access Rick Moore Joseph Ventre
May 21, 2025

What MFN Pricing Initiatives Mean for Manufacturers: Key Insights from the...

3 Minute Read

May 20, 2025, the U.S. Department of Health and Human Services (HHS) issued a significant update on the Executive Order “Delivering Most Favored Nation Prescription Drug Pricing to...

Navigating specialty pharmacy distribution model changes

Market Access Reena Patel
April 24, 2025

Navigating Pharma Distribution Models: Insights from Industry Leaders Part 2

5 Minute Read

Part 2 of our blog examines how new distribution models and market access trends will impact future pharmaceutical strategy.

How Direct-to-Patient Pharma Policies Are Changing

Market Access Blogs Jordan Boruff Ankith Pokkuluri Rick Dutt
March 26, 2025

Direct-to-Patient & Fair Drug Pricing: Reshaping the Pharmacy Landscape

6 Minute Read

This month, we offer commentary on two topics around Direct-to-Patient and the Impact of Maximum Fair Prices on the First 10 Medicare-Negotiated Drugs.

branded prescription drug fee

Contracts & Pricing Nick Lynch
March 13, 2025

2025 Branded Prescription Drug Fees Considerations

3 Minute Read

Keep up-to-date on Branded Prescription Drug Fees with this summary of critical insights from Nick Lynch, Partner at IntegriChain, covering key deadlines and factors.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article